Worth Seeing!
TEDx Talk by Raymond Moses: Empowering the Billion, Unleashing the Investing Potential Watch Now Watch Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 72404.17
1062.22 (-1.45%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
1
Sequent Scientific Ltd.
2,929
(Small Cap)
116.10
(-1.11%)
N/A
4.56
10.88
-288.40
Q V PT
2
Solara Active Pharma Sciences Ltd.
1,816
(Small Cap)
495
(-1.89%)
N/A
1.53
22.61
-221.19
Q V PT
3
Shilpa Medicare Ltd.
5,016
(Small Cap)
498.40
(-2.83%)
N/A
2.19
5.89
-183.46
Q V PT
4
Suven Life Sciences Ltd.
2,282
(Small Cap)
99.50
(-4.92%)
N/A
2.7
-53.54
-163.87
Q V PT
5
Strides Pharma Science Ltd.
7,641
(Small Cap)
827.40
(-0.48%)
102.95
2.16
4.76
-151.49
Q V PT
6
SMS Pharmaceuticals Ltd.
1,759
(Small Cap)
202.50
(-2.53%)
42.3
3.34
2.34
-48.56
Q V+ PT
7
Sastasundar Ventures Ltd.
937
(Small Cap)
283.70
(-3.67%)
N/A
3.44
-100.00
-43.78
Q V PT
8
Glenmark Pharmaceuticals Ltd.
28,804
(Small Cap)
1,001.45
(-1.89%)
N/A
3.24
7.44
-31.19
Q V PT
9
Jubilant Pharmova Ltd.
11,115
(Small Cap)
680.60
(-2.46%)
N/A
4.75
-24.52
-28.13
Q V+ PT
10
Dishman Carbogen Amcis Ltd.
3,251
(Small Cap)
198.80
(-4.12%)
N/A
0.57
7.32
-23.69
Q V PT
11
Aurobindo Pharma Ltd.
66,563
(Mid Cap)
1,118.25
(-1.56%)
33.85
3.45
4.49
-7.93
Q V PT
12
Thyrocare Technologies Ltd.
3,264
(Small Cap)
629.95
(2.19%)
49.77
6.52
8.13
-7.14
Q V PT
13
Hikal Ltd.
3,613
(Small Cap)
288.60
(-1.52%)
50.44
3.11
9.31
-0.88
Q V PT
14
Zydus Lifesciences Ltd.
1,01,202
(Large Cap)
967.80
(-3.77%)
34.03
5.37
7.68
-0.07
Q V PT
15
Innova Captab Ltd.
2,637
(Small Cap)
451.80
(-1.96%)
45.82
2.89
0.00
0.00
Q V PT
16
Unichem Laboratories Ltd.
3,939
(Small Cap)
553.05
(-1.15%)
N/A
1.64
9.99
0.00
Q V PT
17
Max Healthcare Institute Ltd.
78,098
(Mid Cap)
793.55
(-1.24%)
73.89
9.6
21.42
0.00
Q V+ PT
18
Aarti Pharmalabs Ltd.
4,551
(Small Cap)
505
(0.57%)
25.62
2.89
0.00
0.00
Q V+ PT
19
Tarsons Products Ltd.
2,303
(Small Cap)
434.45
(0.36%)
41.66
3.83
0.00
0.00
Q V PT
20
Piramal Pharma Ltd.
20,327
(Small Cap)
148.05
(-3.64%)
127.17
3.17
0.00
0.00
Q V PT
21
Krishna Institute of Medical Sciences Ltd
16,169
(Small Cap)
1,993.35
(-1.34%)
61.75
8.89
12.50
0.00
Q V PT
22
Panacea Biotec Ltd.
840
(Small Cap)
133.80
(-2.44%)
N/A
2.54
-14.85
0.00
Q V PT
23
Jagsonpal Pharmaceuticals Ltd.
888
(Small Cap)
323.05
(-3.85%)
36.24
4.96
13.35
0.00
Q V+ PT
24
Wockhardt Ltd.
8,364
(Small Cap)
531
(-2.61%)
N/A
2.38
-7.60
0.00
Q V PT
25
Blue Jet Healthcare Ltd.
6,566
(Small Cap)
380
(0.40%)
41.03
4
0.00
0.00
Q V+ PT
26
IOL Chemicals And Pharmaceuticals Ltd.
2,239
(Small Cap)
373.15
(-2.16%)
13.05
1.39
0.00
0.00
Q V+ PT
27
Vijaya Diagnostic Centre Ltd.
6,961
(Small Cap)
731.65
(7.75%)
61.67
11.16
0.00
0.00
Q V+ PT
28
Yatharth Hospital & Trauma Care Services Ltd.
3,728
(Small Cap)
432.70
(-0.37%)
58.1
4.6
0.00
0.00
Q V+ PT
29
Concord Biotech Ltd.
16,225
(Small Cap)
1,504.40
(-3.00%)
67.58
11.36
0.00
0.00
Q V PT
30
Suven Pharmaceuticals Ltd.
16,688
(Small Cap)
653.60
(-0.30%)
45
8.42
0.00
0.00
Q V PT
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Vijaya Diagnostic
731.657.75%
RainbowChildrenS Med
1,4083.99%
Thyrocare Tech.
629.952.19%
Ajanta Pharma
2,410.051.82%
Mankind Pharma
2,2121.47%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Suven Life Sciences
99.50-4.92%
Granules India
393.40-4.28%
Dishman Carbogen Amc
198.80-4.12%
Jagsonpal Pharma
323.05-3.85%
Dr. Lal Pathlabs
2,240.45-3.85%
View More

News about Top Pharma Companies in India

Zydus Lifesciences gets USFDA’s approval for Dapsone Gel

Dapsone Gel, 7.5% had annual sales of $35.8 million in the United States
09 May, 2024

Vijaya Diagnostic - Quaterly Results

A fair growth of 19.20% in the revenue at Rs. 1410.52 millions was reported in the March 2024 quarter as compared to Rs. 1183.33 millions during year-ago period.A slim rise of 13.32% was recorded in the Net profit for the quarter ended March 2024 to Rs. 305.09  millions  From Rs. 269.24 millions.Operating Profit saw a handsome growth to 606.57 millions from 526.22 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1410.52 1183.33 19.20 5250.23 4495.79 16.78 5250.23 4495.79 16.78
Other Income 34.06 45.30 -24.81 214.39 145.73 47.11 214.39 145.73 47.11
PBIDT 606.57 526.22 15.27 2336.36 1935.44 20.71 2336.36 1935.44 20.71
Interest 59.48 57.58 3.30 237.08 208.76 13.57 237.08 208.76 13.57
PBDT 547.09 468.64 16.74 2078.78 1726.68 20.39 2078.78 1726.68 20.39
Depreciation 149.07 113.20 31.69 554.06 613.94 -9.75 554.06 613.94 -9.75
PBT 398.02 355.44 11.98 1524.72 1112.74 37.02 1524.72 1112.74 37.02
TAX 92.93 86.20 7.81 378.70 280.39 35.06 378.70 280.39 35.06
Deferred Tax 19.83 8.01 147.57 57.70 5.09 1033.60 57.70 5.09 1033.60
PAT 305.09 269.24 13.32 1146.02 832.35 37.68 1146.02 832.35 37.68
Equity 102.35 102.07 0.27 102.35 102.07 0.27 102.35 102.07 0.27
PBIDTM(%) 43.00 44.47 -3.30 44.50 43.05 3.37 44.50 43.05 3.37
08 May, 2024

Piramal Pharma jumps as its consumer products division launches new digital campaign for 'Polycrol’

This collaboration marks a significant milestone in Polycrol's journey to redefine the narrative surrounding digestive wellness
08 May, 2024

Piramal Pharma’s consumer products division launches new digital campaign for 'Polycrol’

This collaboration marks a significant milestone in Polycrol's journey to redefine the narrative surrounding digestive wellness
07 May, 2024

Suven Life Sciences - Quaterly Results

The sales is pegged at Rs. 23.85 millions for the March 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 26.11 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -31.25 millions as compared to Net Loss of Rs. -22.50 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 further decreased to -25.87% as compared to -5.24% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 23.85 26.11 -8.66 116.93 135.39 -13.63 116.93 135.39 -13.63
Other Income 42.83 56.02 -23.55 211.30 84.49 150.09 211.30 84.49 150.09
PBIDT -25.87 -5.24 393.70 -98.07 -192.95 -49.17 -98.07 -192.95 -49.17
Interest 0.30 0.54 -44.44 1.58 2.89 -45.33 1.58 2.89 -45.33
PBDT -26.17 -5.78 352.77 -25.08 -135.84 -81.54 -25.08 -135.84 -81.54
Depreciation 15.10 16.72 -9.69 65.02 65.43 -0.63 65.02 65.43 -0.63
PBT -41.27 -22.50 83.42 -90.10 -201.27 -55.23 -90.10 -201.27 -55.23
TAX -10.02 0.00 0.00 -10.02 0.00 0.00 -10.02 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -31.25 -22.50 38.89 -80.08 -201.27 -60.21 -80.08 -201.27 -60.21
Equity 218.07 218.07 0.00 218.07 218.07 0.00 218.07 218.07 0.00
PBIDTM(%) -108.47 -20.07 440.49 -83.87 -142.51 -41.15 -83.87 -142.51 -41.15
06 May, 2024

Suven Life Sciences - Quaterly Results

The sales is pegged at Rs. 23.85 millions for the March 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 26.11 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -31.25 millions as compared to Net Loss of Rs. -22.50 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 further decreased to -25.87% as compared to -5.24% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 23.85 26.11 -8.66 116.93 135.39 -13.63 116.93 135.39 -13.63
Other Income 42.83 56.02 -23.55 211.30 84.49 150.09 211.30 84.49 150.09
PBIDT -25.87 -5.24 393.70 -98.07 -192.95 -49.17 -98.07 -192.95 -49.17
Interest 0.30 0.54 -44.44 1.58 2.89 -45.33 1.58 2.89 -45.33
PBDT -26.17 -5.78 352.77 -25.08 -135.84 -81.54 -25.08 -135.84 -81.54
Depreciation 15.10 16.72 -9.69 65.02 65.43 -0.63 65.02 65.43 -0.63
PBT -41.27 -22.50 83.42 -90.10 -201.27 -55.23 -90.10 -201.27 -55.23
TAX -10.02 0.00 0.00 -10.02 0.00 0.00 -10.02 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -31.25 -22.50 38.89 -80.08 -201.27 -60.21 -80.08 -201.27 -60.21
Equity 218.07 218.07 0.00 218.07 218.07 0.00 218.07 218.07 0.00
PBIDTM(%) -108.47 -20.07 440.49 -83.87 -142.51 -41.15 -83.87 -142.51 -41.15
06 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Sequent Scientific Ltd. 2,929 Crore
2 Solara Active Pharma Sciences Ltd. 1,816 Crore
3 Shilpa Medicare Ltd. 5,016 Crore
4 Suven Life Sciences Ltd. 2,282 Crore
5 Strides Pharma Science Ltd. 7,641 Crore
6 SMS Pharmaceuticals Ltd. 1,759 Crore
7 Sastasundar Ventures Ltd. 937 Crore
8 Glenmark Pharmaceuticals Ltd. 28,804 Crore
9 Jubilant Pharmova Ltd. 11,115 Crore
10 Dishman Carbogen Amcis Ltd. 3,251 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,082 18,989 31.48 20.05 21.38 51.69
Abbott India Ltd. (M) Very Good 25,607 55,133 48.13 16.12 32.82 31.69
Laurus Labs Ltd. (S) Very Good 427.1 23,399 145.7 5.69 32.05 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 5,879 1,01,035 18.11 3.58 11.44 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,520 87,583 58.62 12.25 28.15 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Lupin Ltd. (M) Somewhat Good 1,586 73,640 120.7
Zydus Lifesciences Ltd. (L) Very Good 967.8 1,01,202 91.50
Ipca Laboratories Ltd. (M) Very Good 1,283 33,429 87.37
Aurobindo Pharma Ltd. (M) Very Good 1,118 66,563 83.55
Glenmark Pharmaceuticals Ltd. (S) Somewhat Good 1,001 28,804 79.46
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 427.1 23,399 145.7 5.69 32.05 24.05
Granules India Ltd. (S) Somewhat Good 393.4 9,961 21.47 3.31 13.02 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,763 27,838 55.00 9.90 32.50 18.11
Gland Pharma Ltd. (M) Very Good 1,691 28,263 35.28 3.26 20.05 17.42
Mankind Pharma Ltd. (L) Very Good 2,212 87,328 52.92 9.54 36.54 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 427.1 23,399 145.7 5.69 32.05 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 5,879 1,01,035 18.11 3.58 11.44 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,763 27,838 55.00 9.90 32.50 31.92
Biocon Ltd. (M) Somewhat Good 298.9 36,810 19.21 3.38 99.09 31.80
Granules India Ltd. (S) Somewhat Good 393.4 9,961 21.47 3.31 13.02 31.51
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
SEBI Registered: Investment Adviser - INA000013323
Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.